Journal
CELL REPORTS
Volume 5, Issue 1, Pages 61-69Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2013.08.042
Keywords
-
Categories
Funding
- Swedish Research Council, Sweden
- RIKEN Brain Science Institute
- Ministry of Education, Sports, Science and Technology, Japan
- Ministry of Health, Labour and Welfare, Japan
- Grants-in-Aid for Scientific Research [23680039, 11F01512] Funding Source: KAKEN
Ask authors/readers for more resources
Alzheimer's disease (AD) is a neurodegenerative disease biochemically characterized by aberrant protein aggregation, including amyloid beta (A beta) peptide accumulation. Protein aggregates in the cell are cleared by autophagy, a mechanism impaired in AD. To investigate the role of autophagy in A beta pathology in vivo, we crossed amyloid precursor protein (APP) transgenic mice with mice lacking autophagy in excitatory forebrain neurons obtained by conditional knockout of autophagy-related protein 7. Remarkably, autophagy deficiency drastically reduced extracellular A beta plaque burden. This reduction of A beta plaque load was due to inhibition of A beta secretion, which led to aberrant intraneuronal A beta accumulation in the perinuclear region. Moreover, autophagy-deficiency-induced neurodegeneration was exacerbated by amyloidosis, which together severely impaired memory. Our results establish a function for autophagy in A beta metabolism: autophagy influences secretion of A beta to the extracellular space and thereby directly affects A beta plaque formation, a pathological hallmark of AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available